International Vaccine Institute
Clinical trials sponsored by International Vaccine Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cholera vaccine trial aims to protect south africans of all ages Results expected Dec 2026 (estimated)
- Could a malaria vaccine ward off another deadly disease? Results expected Feb 2027 (estimated)
- New cholera vaccine trial aims to protect families in High-Risk areas Results expected Mar 2027 (estimated)
- New cholera pill tested in sweden – first human study begins Results expected Jul 2027 (estimated)
- Massive mpox vaccine trial launches in DRC: could it stop the outbreak? Results expected Aug 2027 (estimated)
-
Massive mpox vaccine trial launches in DRC: could it stop the outbreak?
Vaccine Recruiting nowThis large study will test the LC16m8 mpox vaccine in nearly 12,000 people aged one year and older in the Democratic Republic of Congo. Researchers want to see if the vaccine can prevent mpox disease and monitor its safety. Participants will receive the vaccine as part of the gov…
Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Sep 02, 2026 00:00 UTC
-
New HPV vaccine trial aims to protect kids and teens from cancer
Vaccine Recruiting nowThis study tests a bivalent HPV vaccine in healthy infants (9 months), toddlers (15 months), children (2-5 years), and unmarried young women (15-20 years) in Ghana. Researchers want to see if the vaccine is safe and triggers a strong immune response, especially when given alongsi…
Phase 2 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:34 UTC
-
New cholera vaccine trial aims to protect families in High-Risk areas
Vaccine Recruiting nowThis study tests a new cholera vaccine (OSP:rTTHc CCV) in 390 healthy adults and children aged 1 to 45 in a region where cholera is common. The goal is to see if the vaccine is safe and triggers a strong immune response. Some participants get the vaccine with or without an adjuva…
Phase 2 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:03 UTC
-
New cholera vaccine trial aims to protect south africans of all ages
Vaccine Recruiting nowThis study tests a new oral cholera vaccine (Biovac OCV-S) to see if it works as well as a currently approved vaccine (Euvichol-Plus). About 2,824 healthy people aged 1 to 45, including some adults living with HIV, will receive two doses. Researchers will check immune responses a…
Phase 3 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 08:10 UTC
-
Could a malaria vaccine ward off another deadly disease?
Prevention Recruiting nowThis study looks at whether the R21/Matrix-M malaria vaccine can also reduce the risk of invasive non-typhoidal Salmonella (iNTS), a serious bacterial infection. Researchers will follow 10,000 children under 5 in the Democratic Republic of Congo who come to health centers with fe…
Sponsor: International Vaccine Institute • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC